Turning Evidence into Decisions: Why Value Must Be Understood, Not Just Measured

In many cases, the issue is not the absence of robust data, but the inability to translate that data into a form that resonates with those responsible for acting on it.

Healthcare systems are increasingly sophisticated in how they generate evidence, yet decision making remains fragmented. Clinical leaders, healthcare managers, and policymakers interpret value through fundamentally different lenses, each driven by distinct priorities and constraints.

This challenge is present across all healthcare systems. However, in decentralized environments such as Spain, it becomes more visible and more difficult to manage. The same evidence can be interpreted differently depending on governance structures, organizational cultures, and decision-making dynamics. As a result, value is not only stakeholder-dependent, but also context-dependent.

The consequence is structural. Even well supported interventions may struggle to gain traction if they fail to speak a common language across both roles and settings.

How can a single analytical approach bridge this divide?

Traditional approaches to value assessment tend to evolve in parallel rather than converge into a unified narrative.

Clinical research focuses on efficacy, safety, and patient outcomes. Economic analyses prioritize costs and efficiency. Patient centered perspectives explore quality of life and lived experience.

Each perspective is valid and necessary. However, when presented in isolation, they risk generating incomplete or even conflicting interpretations of value. This fragmentation limits the ability of decision makers to fully understand the broader implications of an intervention, regardless of the system. However, when interpretations also vary across organizational or regional contexts, this fragmentation becomes even more pronounced.

What is needed is not additional evidence, but a structured way to integrate and translate existing evidence across dimensions, stakeholders, and contexts.

Social Return on Investment (SROI) addresses this need by reframing how value is articulated.

Rather than focusing on isolated outcomes, it integrates clinical, economic, and social impact into a single framework. It incorporates the perspectives of multiple stakeholders, including patients, healthcare systems, and society as a whole. It also captures dimensions that are often overlooked in traditional analyses, such as quality-of-life improvements or the burden on informal caregivers.

The output is deliberately simple. A single ratio that expresses the value generated for each unit of investment.

However, the importance of SROI lies less in the metric itself than in its function. It provides a structured way to translate complex, multidimensional evidence into insights that can be interpreted consistently across different decision contexts.

One of the most relevant strengths of SROI is its ability to articulate value simultaneously in terms that are meaningful to different stakeholders.

From a clinical perspective, SROI captures outcomes that directly affect patient health. These include reductions in adverse events, improvements in quality of life, and better disease management over time. Clinical value is preserved and contextualized within a broader framework.

From a managerial perspective, the same analysis provides visibility on efficiency and resource utilization. It links outcomes to avoided costs, optimized care pathways, and more effective allocation of healthcare resources. This translation enables a clearer understanding of operational implications.

From a policy perspective, SROI extends the scope of evaluation beyond the healthcare system. It incorporates societal impact, including productivity losses avoided, reductions in informal care burden, and broader contributions to system sustainability. This dimension is particularly relevant in environments where healthcare decisions must be justified in terms of overall societal value.

By integrating these perspectives, SROI does not simplify complexity. It structures it in a way that supports coherent interpretation.

Healthcare decision making rarely depends on a single viewpoint. It is shaped by the interaction of clinical priorities, operational constraints, and policy objectives. This complexity exists in all health systems. However, in environments with greater organizational or territorial heterogeneity, differences in governance models and decision-making dynamics introduce an additional layer of variability. The relative

weight of clinical, managerial, or policy perspectives may shift across settings, leading to different interpretations of the same evidence.

This variability is a common source of friction. Interventions that generate clear clinical benefit may be delayed due to budgetary constraints in one context, while in another setting, operational considerations or broader societal value may take precedence. The challenge is not only to demonstrate value, but to ensure that value can be understood consistently despite these differences.

In this context, the ability to present value in a way that is simultaneously credible, consistent, and adaptable becomes a critical enabler. SROI contributes precisely at this intersection. It enables organizations to build a shared understanding of value that is robust across decision contexts, and particularly powerful in environments where alignment is more difficult to achieve.